Neoadjuvant Chemoradiotherapy Versus Chemotherapy in Resectable Esophageal and Esophagogastric Junction(EGJ) Cancer: Propensity-Weighted and Matched Analyses of a Histology-Guided Cohort

Indian Journal of Surgery · Published 2026-06-23 · DOI 10.1007/s12262-026-04637-4

Authors (9)

Mayank Tripathi, Reshma R. Balachandran, Vaibhav Kushwaha, Ankita Pal, Chandan Kumar, Piyush Shukla, Paramita Paul, Akhil Kapoor, Ajay Choubey

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tripathi, M., Balachandran, R., Kushwaha, V., et al. (2026). Neoadjuvant Chemoradiotherapy Versus Chemotherapy in Resectable Esophageal and Esophagogastric Junction(EGJ) Cancer: Propensity-Weighted and Matched Analyses of a Histology-Guided Cohort. Indian Journal of Surgery. https://doi.org/10.1007/s12262-026-04637-4

Related articles